Search

Search Results
Results 1 - 10 of 11 for Cancer Research
  • Drug - 9 Jan 2024
    This article will discuss the resurgence in interest in plant-based treatments in modern medicine.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Trizivir intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Nivestim (Filgrastim [rbe]) intended for persons living in Australia.
  • Drug - 23 Nov 2022
    Consumer Medicine Information (CMI) about Erivedge intended for persons living in Australia.
  • Drug - 10 Oct 2022
    Consumer Medicine Information (CMI) about Zostavax intended for persons living in Australia.
  • Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Coveram (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix (indapamide) intended for persons living in Australia.
  • Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.